Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector

By Lewis Krauskopf and Manojna Maddipatla

(Reuters) – Positive clinical trial results for Merck & Co’s experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker’s stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.

Merck shares jumped as much as 12.3% and hit their highest level since February 2020 after data showed the company’s pill molnupiravir…


Source link

About search

Check Also

European Stocks Drop With US Tech Rally Faltering: Markets Wrap – Yahoo Finance

European Stocks Drop With US Tech Rally Faltering: Markets Wrap – Yahoo Finance

[unable to retrieve full-text content]European Stocks Drop With US Tech Rally Faltering: Markets Wrap  Yahoo Finance …

Leave a Reply

Your email address will not be published. Required fields are marked *